159 related articles for article (PubMed ID: 33504255)
1. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
[TBL] [Abstract][Full Text] [Related]
3. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Biomarkers To Stratify Injury Severity and Predict Outcome in Human Traumatic Spinal Cord Injury.
Kwon BK; Streijger F; Fallah N; Noonan VK; Bélanger LM; Ritchie L; Paquette SJ; Ailon T; Boyd MC; Street J; Fisher CG; Dvorak MF
J Neurotrauma; 2017 Feb; 34(3):567-580. PubMed ID: 27349274
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
[TBL] [Abstract][Full Text] [Related]
6. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.
Brophy GM; Mondello S; Papa L; Robicsek SA; Gabrielli A; Tepas J; Buki A; Robertson C; Tortella FC; Hayes RL; Wang KK
J Neurotrauma; 2011 Jun; 28(6):861-70. PubMed ID: 21309726
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
Liu MC; Akinyi L; Scharf D; Mo J; Larner SF; Muller U; Oli MW; Zheng W; Kobeissy F; Papa L; Lu XC; Dave JR; Tortella FC; Hayes RL; Wang KK
Eur J Neurosci; 2010 Feb; 31(4):722-32. PubMed ID: 20384815
[TBL] [Abstract][Full Text] [Related]
8. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers.
Dalkilic T; Fallah N; Noonan VK; Salimi Elizei S; Dong K; Belanger L; Ritchie L; Tsang A; Bourassa-Moreau E; Heran MKS; Paquette SJ; Ailon T; Dea N; Street J; Fisher CG; Dvorak MF; Kwon BK
J Neurotrauma; 2018 Feb; 35(3):435-445. PubMed ID: 29037121
[TBL] [Abstract][Full Text] [Related]
9. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
[TBL] [Abstract][Full Text] [Related]
10. A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury.
Streijger F; Skinnider MA; Rogalski JC; Balshaw R; Shannon CP; Prudova A; Belanger L; Ritchie L; Tsang A; Christie S; Parent S; Mac-Thiong JM; Bailey C; Urquhart J; Ailon T; Paquette S; Boyd M; Street J; Fisher CG; Dvorak MF; Borchers CH; Foster LJ; Kwon BK
J Neurotrauma; 2017 Jun; 34(12):2054-2068. PubMed ID: 28276985
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury.
Tigchelaar S; Gupta R; Shannon CP; Streijger F; Sinha S; Flibotte S; Rizzuto MA; Street J; Paquette S; Ailon T; Charest-Morin R; Dea N; Fisher C; Dvorak MF; Dhall S; Mac-Thiong JM; Parent S; Bailey C; Christie S; Van Keuren-Jensen K; Nislow C; Kwon BK
J Neurotrauma; 2019 Aug; 36(15):2358-2371. PubMed ID: 30827169
[TBL] [Abstract][Full Text] [Related]
12. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure.
Li Y; Wang Z; Zhang B; Zhe X; Wang M; Bai J; Lin T; Zhang S
Epilepsy Res; 2013 Feb; 103(2-3):205-10. PubMed ID: 22920679
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration.
Holmström U; Tsitsopoulos PP; Holtz A; Salci K; Shaw G; Mondello S; Marklund N
Acta Neurochir (Wien); 2020 Sep; 162(9):2075-2086. PubMed ID: 32588294
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
[TBL] [Abstract][Full Text] [Related]
16. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure.
Mondello S; Palmio J; Streeter J; Hayes RL; Peltola J; Jeromin A
BMC Neurol; 2012 Aug; 12():85. PubMed ID: 22931063
[TBL] [Abstract][Full Text] [Related]
18. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning.
Pang L; Wu Y; Dong N; Xu DH; Wang DW; Wang ZH; Li XL; Bian M; Zhao HJ; Liu XL; Zhang N
Clin Biochem; 2014 Jan; 47(1-2):72-6. PubMed ID: 24080464
[TBL] [Abstract][Full Text] [Related]
20. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
